0.8864
price up icon3.15%   0.0271
after-market Dopo l'orario di chiusura: .89 0.0036 +0.41%
loading
Precedente Chiudi:
$0.8593
Aprire:
$0.8767
Volume 24 ore:
112.81K
Relative Volume:
0.12
Capitalizzazione di mercato:
$114.50M
Reddito:
-
Utile/perdita netta:
$-26.91M
Rapporto P/E:
-4.0291
EPS:
-0.22
Flusso di cassa netto:
$-19.57M
1 W Prestazione:
-0.58%
1M Prestazione:
+10.84%
6M Prestazione:
-5.59%
1 anno Prestazione:
-40.11%
Intervallo 1D:
Value
$0.8738
$0.8909
Intervallo di 1 settimana:
Value
$0.8388
$0.93
Portata 52W:
Value
$0.5526
$1.66

Atossa Therapeutics Inc Stock (ATOS) Company Profile

Name
Nome
Atossa Therapeutics Inc
Name
Telefono
206.588.0256
Name
Indirizzo
10202 5TH AVENUE NE, SEATTLE, WA
Name
Dipendente
13
Name
Cinguettio
@atossainc
Name
Prossima data di guadagno
2025-03-25
Name
Ultimi documenti SEC
Name
ATOS's Discussions on Twitter

Confronta ATOS con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
ATOS
Atossa Therapeutics Inc
0.8864 111.00M 0 -26.91M -19.57M -0.22
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
476.95 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.39 60.56B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.64 42.41B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
575.42 34.96B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.83 31.99B 3.81B -644.79M -669.77M -6.24

Atossa Therapeutics Inc Stock (ATOS) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2018-01-26 Iniziato Maxim Group Buy

Atossa Therapeutics Inc Borsa (ATOS) Ultime notizie

pulisher
Jul 23, 2025

What drives Atossa Therapeutics Inc. stock priceExceptional profit potential - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Is Atossa Therapeutics Inc. a good long term investmentRapid wealth creation - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

What analysts say about Atossa Therapeutics Inc. stockTremendous wealth creation - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Why Atossa Therapeutics Inc. stock attracts strong analyst attentionHigh Potential Safe Trades - Newser

Jul 22, 2025
pulisher
Jul 20, 2025

Atossa Therapeutics Inc. Stock Analysis and ForecastMarket-leading growth rates - jammulinksnews.com

Jul 20, 2025
pulisher
Jul 18, 2025

Should I buy Atossa Therapeutics Inc. stock before earningsHigh Win Rate Stock Ideas - Newser

Jul 18, 2025
pulisher
Jul 15, 2025

How Atossa Therapeutics Inc. stock performs during market volatilityDaily Gain Forecast - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Atossa Therapeutics Inc. stock price move sharplyTrade With Low Risk Exposure - Newser

Jul 15, 2025
pulisher
Jul 07, 2025

Ascendiant Lifts Atossa Therapeutics, Inc. (ATOS) Target Citing Strong Liquidity - MSN

Jul 07, 2025
pulisher
Jun 26, 2025

15 Best Growth Stocks to Invest in for the Next 5 Years - Insider Monkey

Jun 26, 2025
pulisher
Jun 15, 2025

Millennium Management LLC Purchases Shares of 29,149 Atossa Therapeutics, Inc. (NASDAQ:ATOS) - Defense World

Jun 15, 2025
pulisher
Jun 09, 2025

Atossa Therapeutics, Inc. (NASDAQ:ATOS) Shares Purchased by Two Sigma Advisers LP - Defense World

Jun 09, 2025
pulisher
Jun 07, 2025

Ascendiant Capital Markets Issues Positive Forecast for Atossa Therapeutics (NASDAQ:ATOS) Stock Price - Defense World

Jun 07, 2025
pulisher
Jun 07, 2025

Craig Hallum Upgrades Atossa Therapeutics (NASDAQ:ATOS) to “Strong-Buy” - Defense World

Jun 07, 2025
pulisher
Jun 06, 2025

Atossa Therapeutics (ATOS): Ascendiant Capital Raises Price Targ - GuruFocus

Jun 06, 2025
pulisher
Jun 06, 2025

Ascendiant Capital raises Atossa Genetics stock price target to $7.50 By Investing.com - Investing.com India

Jun 06, 2025
pulisher
Jun 06, 2025

Ascendiant Capital raises Atossa Genetics stock price target to $7.50 - Investing.com

Jun 06, 2025
pulisher
Jun 06, 2025

Craig-Hallum Initiates Coverage of Atossa Therapeutics (BMV:ATOS) with Buy Recommendation - Nasdaq

Jun 06, 2025
pulisher
Jun 05, 2025

Craig-Hallum Initiates Coverage of Atossa Therapeutics (ATOS) with Buy Recommendation - Nasdaq

Jun 05, 2025
pulisher
Jun 05, 2025

This Excelerate Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Benzinga

Jun 05, 2025
pulisher
Jun 05, 2025

Craig-Hallum Initiates Coverage on Atossa Therapeutics (ATOS) with Buy Rating | ATOS Stock News - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

Atossa Therapeutics at Jefferies Conference: Strategic Moves in Breast Cancer - Investing.com Canada

Jun 05, 2025
pulisher
Jun 05, 2025

Craig-Hallum initiates Atossa Genetics stock with buy rating By Investing.com - Investing.com UK

Jun 05, 2025
pulisher
Jun 05, 2025

Atossa Therapeutics (ATOS) Receives Buy Rating with Promising Ca - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

Atossa Therapeutics (ATOS) Receives Buy Rating with Promising Cancer Drug Potential | ATOS Stock News - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

Craig Hallum Initiates Coverage on Atossa Therapeutics With Buy Rating, $4 Price Target - MarketScreener

Jun 05, 2025
pulisher
Jun 05, 2025

Atossa Therapeutics (ATOS) Receives Positive Coverage and Price Target | ATOS Stock News - GuruFocus

Jun 05, 2025
pulisher
Jun 02, 2025

Atossa Therapeutics to Present at the Jefferies Global Healthcare Conference - Bluefield Daily Telegraph

Jun 02, 2025
pulisher
Jun 02, 2025

Atossa Therapeutics to Present at the Jefferies Global Healthcare Conference | ATOS Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Atossa Therapeutics CEO Reveals Latest Breast Cancer Drug Progress at Major Healthcare Conference - Stock Titan

Jun 02, 2025
pulisher
May 30, 2025

Atossa Therapeutics, Inc. (NASDAQ:ATOS) Shares Acquired by Northern Trust Corp - Defense World

May 30, 2025

Atossa Therapeutics Inc Azioni (ATOS) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$22.87
price up icon 4.91%
$36.01
price down icon 0.25%
$103.44
price up icon 0.51%
$28.01
price up icon 5.54%
$114.60
price up icon 2.84%
biotechnology ONC
$294.83
price down icon 0.26%
Capitalizzazione:     |  Volume (24 ore):